Optumcare Medical Group - Medicare Primary Care in Los Alamitos, CA

Optumcare Medical Group is a medicare enrolled primary clinic (Family Medicine) in Los Alamitos, California. The current practice location for Optumcare Medical Group is 3460 Katella Ave, Los Alamitos, California. For appointments, you can reach them via phone at (562) 594-6599. The mailing address for Optumcare Medical Group is 11 Technology Dr, Irvine, California and phone number is (949) 923-3277.

Optumcare Medical Group is licensed to practice in * (Not Available) (license number ). The clinic also participates in the medicare program and its NPI number is 1467598243. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (562) 594-6599.

Contact Information

Optumcare Medical Group
3460 Katella Ave
Los Alamitos
CA 90720-2334
(562) 594-6599
(562) 598-6220

Primary Care Clinic Profile

Full NameOptumcare Medical Group
SpecialityFamily Medicine
Location3460 Katella Ave, Los Alamitos, California
Authorized Official Name and PositionErin Warner (SR. CREDENTIALING REPRESENTATIVE)
Authorized Official Contact9499233240
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Optumcare Medical Group
11 Technology Dr
Irvine
CA 92618-2302

Ph: (949) 923-3277
Optumcare Medical Group
3460 Katella Ave
Los Alamitos
CA 90720-2334

Ph: (562) 594-6599

NPI Details:

NPI Number1467598243
Provider Enumeration Date01/29/2007
Last Update Date04/25/2016

Medicare PECOS Information:

Medicare PECOS PAC ID9931143799
Medicare Enrollment IDO20050614000191

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Medical Identifiers

Medical identifiers for Optumcare Medical Group such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1467598243NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Q00000XFamily Medicine (* (Not Available))Primary
207R00000XInternal Medicine (* (Not Available))Secondary
207RE0101XInternal Medicine - Endocrinology, Diabetes & Metabolism (* (Not Available))Secondary
207V00000XObstetrics & Gynecology (* (Not Available))Secondary
208000000XPediatrics (* (Not Available))Secondary
208M00000XHospitalist (* (Not Available))Secondary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Optumcare Medical Group acts as a billing entity for following providers:
Provider NameStefanie J Fightlin
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1386640746
PECOS PAC ID: 7911803093
Enrollment ID: I20031209001131

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameBenhoor Khalpari
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1689762197
PECOS PAC ID: 8921904863
Enrollment ID: I20031211000333

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameMahshid Elmzadeh
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1760574164
PECOS PAC ID: 9032015979
Enrollment ID: I20031211000502

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameSullyvan W Tang
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1770549206
PECOS PAC ID: 6608769450
Enrollment ID: I20040205000215

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameFarideh F Bahrami
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1083675821
PECOS PAC ID: 1759277676
Enrollment ID: I20040226000329

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameSteven A Maier
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1750359931
PECOS PAC ID: 1456349133
Enrollment ID: I20040503000585

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NamePeter S Park
Provider TypePractitioner - Podiatry
Provider IdentifiersNPI Number: 1104825033
PECOS PAC ID: 3971587353
Enrollment ID: I20040614001647

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameRolf Didrek Knapp
Provider TypePractitioner - Osteopathic Manipulative Medicine
Provider IdentifiersNPI Number: 1053355982
PECOS PAC ID: 3779562822
Enrollment ID: I20040714000501

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameJennifer Hung
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1528118395
PECOS PAC ID: 9335129030
Enrollment ID: I20040722001308

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameHoward K Bland
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1336156769
PECOS PAC ID: 4486626306
Enrollment ID: I20040811000547

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameLawrence D Wong
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1972681963
PECOS PAC ID: 7113915299
Enrollment ID: I20040830000357

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameOwrang Dastmalchi
Provider TypePractitioner - Hospice/palliative Care
Provider IdentifiersNPI Number: 1922049188
PECOS PAC ID: 9133194095
Enrollment ID: I20040903000273

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameSiamak Tehrani Nabili
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1407892490
PECOS PAC ID: 7719953876
Enrollment ID: I20040909000521

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameTengis R Riznis
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1821155326
PECOS PAC ID: 2163499062
Enrollment ID: I20040910001029

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameBijan Dowlati
Provider TypePractitioner - Dermatology
Provider IdentifiersNPI Number: 1346297108
PECOS PAC ID: 3173591393
Enrollment ID: I20040923001295

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameJacquelyn V Vander Wall
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1699807792
PECOS PAC ID: 6002871506
Enrollment ID: I20041123001272

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameNora M Oakley
Provider TypePractitioner - Chiropractic
Provider IdentifiersNPI Number: 1952490922
PECOS PAC ID: 7012960784
Enrollment ID: I20050223000342

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameCharles M Maples
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1215033808
PECOS PAC ID: 9537116405
Enrollment ID: I20050404000216

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameVu Q Phan
Provider TypePractitioner - Hematology/oncology
Provider IdentifiersNPI Number: 1831247667
PECOS PAC ID: 7012955339
Enrollment ID: I20050418001311

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameSteven J Becker
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1447348628
PECOS PAC ID: 4284674094
Enrollment ID: I20050510001240

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameGregory R Kimball
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1376553123
PECOS PAC ID: 3274574504
Enrollment ID: I20050517001045

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameNghi D Vo
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1255410320
PECOS PAC ID: 1456380328
Enrollment ID: I20050810001145

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameRoger Nguyen Tran
Provider TypePractitioner - Geriatric Medicine
Provider IdentifiersNPI Number: 1649234949
PECOS PAC ID: 9234103953
Enrollment ID: I20051128000255

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameBakulkumar K Patel
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1710932751
PECOS PAC ID: 1456372556
Enrollment ID: I20051219000603

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameJyotin K Patel
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1275598765
PECOS PAC ID: 8729009717
Enrollment ID: I20051220000629

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameChristopher P Nguyen
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1588624100
PECOS PAC ID: 5890718589
Enrollment ID: I20060110000321

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameMitchell J Wainwright
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1730138678
PECOS PAC ID: 8325052806
Enrollment ID: I20060203000573

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameRonald D Richmond
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1255337713
PECOS PAC ID: 1355359654
Enrollment ID: I20060328000774

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameViet H Nguyen
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1770528515
PECOS PAC ID: 1456356047
Enrollment ID: I20061004000180

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameThuy Adrianne Nguyen
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1386688471
PECOS PAC ID: 8325044332
Enrollment ID: I20061016000226

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameSimona D Pop
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1275564874
PECOS PAC ID: 9537168380
Enrollment ID: I20061205000725

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameRajnish Birla
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1477627065
PECOS PAC ID: 2466453238
Enrollment ID: I20070122000304

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameKambiz V Karimi
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1184688475
PECOS PAC ID: 9436251121
Enrollment ID: I20070227000437

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameDorothy Ulit
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1134274244
PECOS PAC ID: 0042301210
Enrollment ID: I20070802000566

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameAmar A Kadakia
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1649386210
PECOS PAC ID: 2567555139
Enrollment ID: I20070912000746

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameRahele Mazarei
Provider TypePractitioner - Obstetrics/gynecology
Provider IdentifiersNPI Number: 1639170459
PECOS PAC ID: 9537256805
Enrollment ID: I20071102000330

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameLinda Alimadadian
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1891711065
PECOS PAC ID: 5193813350
Enrollment ID: I20071121000519

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameShahab Zahed
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1780690131
PECOS PAC ID: 9931154135
Enrollment ID: I20080312000773

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameElmo M Agatep
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1043228224
PECOS PAC ID: 9638257843
Enrollment ID: I20080428000593

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameHadi Mansoury
Provider TypePractitioner - Nephrology
Provider IdentifiersNPI Number: 1922175413
PECOS PAC ID: 9537236781
Enrollment ID: I20080930000376

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameYelena Wood
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1821091174
PECOS PAC ID: 6800856832
Enrollment ID: I20081023000855

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameLinda M Fitzgerald
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1790719847
PECOS PAC ID: 8628126711
Enrollment ID: I20090429000288

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameTheresa L Wilson
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1760631592
PECOS PAC ID: 2769534536
Enrollment ID: I20090709000400

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameJun Liu
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1770669319
PECOS PAC ID: 5294889796
Enrollment ID: I20090818000695

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameErik J Geiger
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1255490199
PECOS PAC ID: 7416001912
Enrollment ID: I20090818000748

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameRichard Y Appel
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1336225044
PECOS PAC ID: 6406900919
Enrollment ID: I20090818000772

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameNavid Geula
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1487820577
PECOS PAC ID: 4082769286
Enrollment ID: I20090910000525

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameLynn D Tran
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1942355037
PECOS PAC ID: 9133266570
Enrollment ID: I20091016000509

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameMark D Hauptman
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1801873427
PECOS PAC ID: 8022098300
Enrollment ID: I20091102000631

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameJohn D Millane
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1801879093
PECOS PAC ID: 3779622618
Enrollment ID: I20091205000097

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameKaren K Lau
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1548595580
PECOS PAC ID: 5496895013
Enrollment ID: I20091211000667

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameMohana S Kulkarni
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1457419236
PECOS PAC ID: 8123104916
Enrollment ID: I20100209000261

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameCordelia C Sotelo
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1982859633
PECOS PAC ID: 5597809319
Enrollment ID: I20100217000591

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameJuan M Cabrera
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1447254792
PECOS PAC ID: 0648378463
Enrollment ID: I20100511000637

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameShaparak Montakhab Kamarei
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1952409021
PECOS PAC ID: 6406980069
Enrollment ID: I20100818000227

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameLothar Mcmillian
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1588748891
PECOS PAC ID: 4284759036
Enrollment ID: I20100916000523

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameErin E Parise
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1225282775
PECOS PAC ID: 4789877994
Enrollment ID: I20101020001060

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameNancy A Smith
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1760442339
PECOS PAC ID: 3173717006
Enrollment ID: I20101104000269

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameRudolf Haider
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1740249069
PECOS PAC ID: 0749474682
Enrollment ID: I20101104000350

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameEllen Dayon
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1043279359
PECOS PAC ID: 6305032285
Enrollment ID: I20101118000762

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameRobert Henry Barron
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1477626984
PECOS PAC ID: 2668668351
Enrollment ID: I20101119000914

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameGary Paul Korff
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1063585495
PECOS PAC ID: 2062608771
Enrollment ID: I20101119001120

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameGary L Kobayashi
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1245303353
PECOS PAC ID: 7517153984
Enrollment ID: I20101124000397

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameAlonzo J Flores
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1518013978
PECOS PAC ID: 5496944183
Enrollment ID: I20110111000892

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameSophia N Chun
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1104939990
PECOS PAC ID: 3971783929
Enrollment ID: I20110208000352

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameJasia Hu
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1568617348
PECOS PAC ID: 2264613520
Enrollment ID: I20110221000683

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameAndrew Hall
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1154494565
PECOS PAC ID: 8123209277
Enrollment ID: I20110222000826

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameDan T Nguyen
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1821398314
PECOS PAC ID: 4981874021
Enrollment ID: I20110830000013

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameKaren Rasmussen
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1750510368
PECOS PAC ID: 2365613205
Enrollment ID: I20110926000166

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameMatthew Davis
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1134148133
PECOS PAC ID: 0446436000
Enrollment ID: I20111108000215

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameDeborah L Pauer
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1073532065
PECOS PAC ID: 9830189778
Enrollment ID: I20111108000319

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameAbelardo R Pita
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1831118900
PECOS PAC ID: 6901896844
Enrollment ID: I20120125000731

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameJames Joseph Burris
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1811082415
PECOS PAC ID: 4880852920
Enrollment ID: I20120221000854

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameDavid S Zimmerman
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1255357307
PECOS PAC ID: 8123288420
Enrollment ID: I20120323000321

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameGloria C Hu
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1396062279
PECOS PAC ID: 6305002528
Enrollment ID: I20120716000441

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameCindy C Zia
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1760759906
PECOS PAC ID: 7618123936
Enrollment ID: I20120801000855

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameFrancisco S Perez
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1841262763
PECOS PAC ID: 5092748996
Enrollment ID: I20121102000293

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameKeith E Penera
Provider TypePractitioner - Podiatry
Provider IdentifiersNPI Number: 1982834347
PECOS PAC ID: 3870747181
Enrollment ID: I20130213000272

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameTeresa Grant
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1174816953
PECOS PAC ID: 2860663440
Enrollment ID: I20130304000126

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameShahnoos Mahdavi
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1013163294
PECOS PAC ID: 8820157845
Enrollment ID: I20130306000152

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NamePaul D Sychangco
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1053569483
PECOS PAC ID: 5890932875
Enrollment ID: I20130510000399

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameHouman D Danesh
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1205027802
PECOS PAC ID: 2860573300
Enrollment ID: I20130603000224

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameChristine L Carreon
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1972658375
PECOS PAC ID: 1153561469
Enrollment ID: I20130710000581

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameLisa A Baldwin
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1619182656
PECOS PAC ID: 5890935746
Enrollment ID: I20130717000492

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameLaura L Mc Ewan
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1437472016
PECOS PAC ID: 9931335478
Enrollment ID: I20131112000106

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameCindy C Jen
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1104123199
PECOS PAC ID: 0547496317
Enrollment ID: I20131127000085

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NamePourya Mirsaeid Ghazi
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1295047892
PECOS PAC ID: 5991946998
Enrollment ID: I20140121001878

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameSean Shahamiri
Provider TypePractitioner - Critical Care (intensivists)
Provider IdentifiersNPI Number: 1508135633
PECOS PAC ID: 4587881297
Enrollment ID: I20140804001048

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameRichard Han Lee
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1538454392
PECOS PAC ID: 4587884077
Enrollment ID: I20141006000170

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameEhsan Ghetmiri
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1083908396
PECOS PAC ID: 5698997401
Enrollment ID: I20141112000015

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameEzioma Azubuike
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1659774560
PECOS PAC ID: 4880918622
Enrollment ID: I20150127000008

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameNidal Al Hannat
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1235335563
PECOS PAC ID: 1759575624
Enrollment ID: I20150410002602

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameSubrato Ghosh
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1083607055
PECOS PAC ID: 5193997617
Enrollment ID: I20150526001962

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameRonald Lee
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1417954306
PECOS PAC ID: 6103806278
Enrollment ID: I20151006002798

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameMarco A Lopez-vizcarra
Provider TypePractitioner - Neurology
Provider IdentifiersNPI Number: 1467663963
PECOS PAC ID: 8820286800
Enrollment ID: I20151008002338

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameSophia Lazo Molina
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1740606870
PECOS PAC ID: 6901118090
Enrollment ID: I20151112000590

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameTerisa M Sienko
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1629081138
PECOS PAC ID: 6800028903
Enrollment ID: I20160217002013

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameDora Akuetteh Saforo
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1083616783
PECOS PAC ID: 5294031217
Enrollment ID: I20160316002325

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameNima Taheri
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1073856837
PECOS PAC ID: 0345531893
Enrollment ID: I20160614001388

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameMichelle Kathleen Casanova
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1528457249
PECOS PAC ID: 7416236385
Enrollment ID: I20161116002398

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameAngelina M Arturo
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1417151705
PECOS PAC ID: 9234365156
Enrollment ID: I20170213001322

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameKym Ysabel K Golla
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1700338118
PECOS PAC ID: 6406132885
Enrollment ID: I20170419002308

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameStefan Cadag
Provider TypePractitioner - Endocrinology
Provider IdentifiersNPI Number: 1841408721
PECOS PAC ID: 5092908954
Enrollment ID: I20170621001971

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NamePratik Gandhi
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1811314941
PECOS PAC ID: 0547531568
Enrollment ID: I20170809000620

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameEleia F Bibay
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1225427941
PECOS PAC ID: 9133493505
Enrollment ID: I20170922003435

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameGregory Gee
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1831595339
PECOS PAC ID: 5890089833
Enrollment ID: I20171221000264

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameErinn Carusetta
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1043729825
PECOS PAC ID: 4688935984
Enrollment ID: I20180301001308

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameStephanie L Fanous
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1306344122
PECOS PAC ID: 9436236296
Enrollment ID: I20180323001409

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameMarcus Allan P Mercado
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1760896336
PECOS PAC ID: 0648532903
Enrollment ID: I20180326001596

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameBassam R Bilal
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1306890827
PECOS PAC ID: 8426941352
Enrollment ID: I20180413000588

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameBridget Mary Moran
Provider TypePractitioner - Certified Nurse Midwife (cnm)
Provider IdentifiersNPI Number: 1568668689
PECOS PAC ID: 9032467808
Enrollment ID: I20180810000512

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameSusan Tang
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1952780017
PECOS PAC ID: 2860741527
Enrollment ID: I20180814002778

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameFaranak C Ghazi
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1194111070
PECOS PAC ID: 9032470240
Enrollment ID: I20180905000973

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameMary Ann M Tanglao
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1134632490
PECOS PAC ID: 7911258108
Enrollment ID: I20180927001382

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameRyan N Tran
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1790758068
PECOS PAC ID: 4688842610
Enrollment ID: I20181121000495

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameTracy Yen-lin Driver
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1982048112
PECOS PAC ID: 1355680141
Enrollment ID: I20190221001506

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameKelly Gee
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1841677390
PECOS PAC ID: 3274844758
Enrollment ID: I20190408000716

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameStacie B Groat
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1821555087
PECOS PAC ID: 7810220779
Enrollment ID: I20190607000293

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameJonathan T Oishi
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1396109781
PECOS PAC ID: 2264760172
Enrollment ID: I20190829002609

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameDavid Rae Park
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1003855313
PECOS PAC ID: 8921077157
Enrollment ID: I20190916000807

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameMahsa Safavi
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1619521556
PECOS PAC ID: 4284964545
Enrollment ID: I20190930001212

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameAngela Chung
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1326569419
PECOS PAC ID: 1951633874
Enrollment ID: I20191025002378

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameAli Ahoui
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1093964769
PECOS PAC ID: 3072821537
Enrollment ID: I20200416000816

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameBerk Tolga Suntay
Provider TypePractitioner - Obstetrics/gynecology
Provider IdentifiersNPI Number: 1841429974
PECOS PAC ID: 0840599106
Enrollment ID: I20200519001226

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameEthan Thien Nguyen
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1568475614
PECOS PAC ID: 4688602048
Enrollment ID: I20200722003626

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameNiroshan Kirupananthan
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1366883068
PECOS PAC ID: 8729377759
Enrollment ID: I20210408002296

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameAta Soleimani Rahbar
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1487059192
PECOS PAC ID: 0042584856
Enrollment ID: I20210728002155

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameKarren L Tan
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1578226064
PECOS PAC ID: 9436545597
Enrollment ID: I20220330000881

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameSophia Tran
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1952862922
PECOS PAC ID: 4789083486
Enrollment ID: I20220614001154

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameMa Susana Echeverria Spitz
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1942780002
PECOS PAC ID: 0042552515
Enrollment ID: I20220720003044

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameAllen Kris Navarro
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1679237598
PECOS PAC ID: 9830570894
Enrollment ID: I20220721002706

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameGolshan Fahimi
Provider TypePractitioner - Neurology
Provider IdentifiersNPI Number: 1376066548
PECOS PAC ID: 2668719261
Enrollment ID: I20220907003112

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameAnas M Aljammal
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1437611464
PECOS PAC ID: 4183009608
Enrollment ID: I20220920003023

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameCamellia Shoapour
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1154883940
PECOS PAC ID: 2365818499
Enrollment ID: I20221014001399

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameLisa Shue
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1851928196
PECOS PAC ID: 7315315538
Enrollment ID: I20230306000243

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameAmir Morcos Mekhail
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1699236323
PECOS PAC ID: 6204248818
Enrollment ID: I20230425001742

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameMaia Ahmad Orabi
Provider TypePractitioner - Preventive Medicine
Provider IdentifiersNPI Number: 1841638491
PECOS PAC ID: 9830457548
Enrollment ID: I20230620003415

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameLauren Helena Canchola
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1871202051
PECOS PAC ID: 8628436797
Enrollment ID: I20230621003280

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameSe Young Cho
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1538796222
PECOS PAC ID: 8527426436
Enrollment ID: I20230626001871

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameFatemeh Jafari Farshami
Provider TypePractitioner - Rheumatology
Provider IdentifiersNPI Number: 1386049260
PECOS PAC ID: 6507171352
Enrollment ID: I20230801000668

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameMaryam Nemati
Provider TypePractitioner - Endocrinology
Provider IdentifiersNPI Number: 1750872305
PECOS PAC ID: 1557722808
Enrollment ID: I20230802002360

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameJonathan Corrales Maganis
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1235750209
PECOS PAC ID: 5799147393
Enrollment ID: I20230814003879

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

Provider NameJ'aime Christine Moehlman
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1770080087
PECOS PAC ID: 9537513320
Enrollment ID: I20230927003476

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more Medical News

› Verified 8 days ago

News Archive

Study reinforces significance of raising young children in stimulating environments

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements.

G8 nations should increase aid to Africa to meet 2010 targets

The Group of Eight industrialized nations should increase assistance to Africa in order to meet pledges to double aid to the continent by 2010, according to a report released on Monday in London by the Africa Progress Panel, the Washington Post reports.

FDA advisory committee supports lorcaserin for weight management

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to 4, with one abstention, that the available data demonstrate that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Stanford scientists model how rising temperatures may influence mosquito behavior and disease risk

As temperatures rise with climate change, mosquito season extends past the summer months in many parts of the world. The question has been how this lengthened season influences the risk of being infected with mosquito-born diseases such as dengue, chikungunya, and Zika.

Read more News

› Verified 8 days ago


Family Medicine in Los Alamitos, CA

Ghulam Y Dostzada Md Inc
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 5300 Katella Ave, Los Alamitos, CA 90720
Phone: 562-799-0383    
Charles M Maples
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 3771 Katella Ave, Suite 110, Los Alamitos, CA 90720
Phone: 562-430-6850    Fax: 562-280-2882
Socal Gastroenterology Corp.
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 10931 Cherry St Ste 300, Los Alamitos, CA 90720
Phone: 562-493-1011    Fax: 562-594-9226
Prohealth Partners, A Medical Group, Inc.
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 3791 Katella Ave Ste 101, Los Alamitos, CA 90720
Phone: 562-446-0580    
Alexandra A Chrysanthis M D Inc
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 10861 Cherry St # 210, Los Alamitos, CA 90720
Phone: 562-795-6406    Fax: 562-795-6409
Cancer And Blood Specialty Clinic
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 3851 Katella Ave, Suite 125, Los Alamitos, CA 90720
Phone: 562-735-0602    Fax: 562-490-8590
T.h. Choi, A Medical Corp.
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 3771 Katella Ave, Suite 300, Los Alamitos, CA 90720
Phone: 562-430-7533    Fax: 425-928-4044

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.